Breaking News Instant updates and real-time market news.

HD

Home Depot

$238.98

1.64 (0.69%)

, MDT

Medtronic

$111.25

-0.86 (-0.77%)

20:25
11/18/19
11/18
20:25
11/18/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Home Depot (HD), consensus $2.52... Medtronic (MDT), consensus $1.28... TJX Companies (TJX), consensus 66c... TransDigm Group (TDG), consensus $5.24... Aramark (ARMK), consensus 69c... Kohl's (KSS), consensus 86c.

HD

Home Depot

$238.98

1.64 (0.69%)

MDT

Medtronic

$111.25

-0.86 (-0.77%)

TJX

TJX

$59.54

-0.25 (-0.42%)

TDG

TransDigm

$568.32

9.81 (1.76%)

ARMK

Aramark

$43.90

0.25 (0.57%)

KSS

Kohl's

$58.39

-0.71 (-1.20%)

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 05

    Dec

  • 11

    Dec

HD Home Depot
$238.98

1.64 (0.69%)

11/07/19
NOMU
11/07/19
INITIATION
Target $240
NOMU
Neutral
Home Depot initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Michael Baker initiated coverage of Home Depot with a Neutral rating and $240 price target. The analyst says the company is taking share in-store and online amid rebounding trends in housing, but he also sees its current valuation leaving "limited upside" to its stock price.
11/11/19
EDJN
11/11/19
DOWNGRADE
EDJN
Hold
Home Depot downgraded to Hold from Buy at Edward Jones
Edward Jones analyst Brian Yarbrough downgraded Home Depot to Hold from Buy.
11/07/19
NOMU
11/07/19
INITIATION
Target $132
NOMU
Buy
Lowe's initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Baker initiated coverage of Lowe's (LOW) with a Buy rating and $132 price target. The analyst calls the company a turnaround story helped by the favorable macro backdrop that should act as a tailwind. Baker believes Lowe's can generate significantly higher earnings as it closes the gap relative to Home Depot (HD).
11/15/19
JEFF
11/15/19
NO CHANGE
Target $268
JEFF
Buy
Home Depot price target raised to $268 from $246 at Jefferies
Jefferies analyst Jonathan Matuszewski raised his price target for Home Depot (HD) to $268 from $246 and keeps a Buy rating on the shares. The analyst also raised his price target for Buy-rated Lowe's (LOW) to $130 from $125. The analyst's channel checks point to Home Depot outperforming in brick and mortar as well as e-commerce in Q3. As a result, he lowered his Lowe's comp estimate below the consensus and raised his Home Depot comp estimate above the Street.
MDT Medtronic
$111.25

-0.86 (-0.77%)

11/05/19
PIPR
11/05/19
NO CHANGE
PIPR
Overweight
Medtronic filed patent lawsuit against Axonics, says Piper Jaffray
Piper Jaffray analyst Adam Maeder says Medtronic (MDT) yesterday filed a lawsuit with the U.S. District Court for the Central District of California alleging that Axonics Modulation Technologies' rechargeable sacral neuromodulation system infringes its U.S. patents. As part of the lawsuit, Medtronic is seeking injunctive relief and damages for alleged intellectual property infringement, the analyst points out. The timing of the lawsuit coincides with Axonics' U.S. commercial launch, says Maeder, who points out that patent litigation is not uncommon in the medical device sector and generally takes a while to play out. He expects Axonics to "defend itself vigorously and continue to sell r-SNM throughout the ongoing legal process."
11/01/19
PIPR
11/01/19
INITIATION
Target $39
PIPR
Overweight
Axonics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Adam Maeder initiated coverage of Axonics Modulation Technologies (AXNX) with an Overweight rating and $39 price target. Although there is some investor disappointment that U.S. launch didn't commence sooner and urinary approval is still pending, Axonics remains positioned for commercial success and "strong" sales growth next year, Maeder tells investors in a research note. He believes the company's r-SNM has meaningful advantages over Medtronic's (MDT) InterStim II product and sees "plenty of room in the market for a second competitor."
09/25/19
GUGG
09/25/19
NO CHANGE
GUGG
Neutral
Medtronic financial projections for Hugo robot 'underwhelming,' says Guggenheim
After attending Medtronic's (MDT) "much-anticipated" robotic-assisted surgery event, where the company gave a first look at the Hugo RAS system, Guggenheim analyst Chris Pasquale noted that the company gave an update on regulatory timelines and initial revenue targets, though information on pricing and clinical comparability to Intuitive Surgical's (ISRG) da Vinci system were "notably absent." He was impressed by certain design elements, though he thinks management's financial projections for Hugo were "somewhat underwhelming," said Pasquale, who keeps a Neutral rating on Medtronic shares.
09/27/19
PIPR
09/27/19
NO CHANGE
PIPR
Piper says insulin pump survey most positive for Insulet
Piper Jaffray analyst JP McKim conducted an insulin delivery survey in August and found that pump penetration is going "much higher" both in type 1s and in type 2s. The growth in the type 2 market is underappreciated by investors and will largely benefit Insulet (PODD) today given the pharmacy channel increases that access, McKim tells investors in a research note. Further, survey indicated that Medtronic (MDT) is expected to lose between 1,100-1,300 basis points of market share with Tandem Diabetes (TNDM) being the greatest beneficiary with the biggest uptick forecast in 2020, says the analyst. McKim views the insulin pump survey as most positive for Insulet.
TJX TJX
$59.54

-0.25 (-0.42%)

11/07/19
NOMU
11/07/19
INITIATION
Target $65
NOMU
Buy
TJX initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Baker initiated coverage of TJX with a Buy rating and $65 price target. The analyst says the company's "attractive" retailing segment has built up "good momentum", which is allowing it to gain market share from weaker channels. Baker also sees TJX generating positive inflection in its international business.
11/11/19
RBCM
11/11/19
INITIATION
Target $60
RBCM
Sector Perform
TJX initiated with a Sector Perform at RBC Capital
RBC Capital analyst Kate Fitzsimons initiated coverage of TJX with a Sector Perform rating and $60 price target. The analyst is positive on the company's "multiple revenue levels", but also expects its growth rate to remain in the 5%-6% range over the coming years because of margin pressure from company-specific and external headwinds. Fitzsimons adds that the premium valuation on TJX is unlikely to re-rate higher, and she sees "more robust algorithms" in other sector names.
11/14/19
GUGG
11/14/19
NO CHANGE
Target $66
GUGG
Buy
Guggenheim raises price targets on off-price retailers TJX, Ross Stores
Guggenheim analyst Robert Drbul said the off-price sector remains one of his favorites in U.S. retail and he believes the environment will be supportive this holiday and in 2020 based on the inventory imbalance he sees in the marketplace today, which should create a product/buying environment that supports continued revenue gains. He predicts a return to postive double digit percentage earnings growth in 2020 and raised his price target on TJX (TJX) shares to $66 from $60 and his price target for Ross Stores (ROST) to $125 from $120. He has Buy ratings on both stocks. Elsewhere in the group, he keeps Neutral ratings on Burlington Stores (BURL), Nordstrom (JWN) and Macy's (M).
11/12/19
LEHM
11/12/19
INITIATION
Target $66
LEHM
Overweight
TJX initiated with an Overweight at Barclays
Barclays analyst Adrienne Yih initiated coverage of TJX with an Overweight rating and $66 price target. The analyst is positive on the company's position as the "largest global off-price retailer" based on sales in North America, Europe, and Australia, its ability to take advantage of sector inventory dislocations, and the "defensive nature" of its business model. Yih adds that the company should see some relief from freight and wage pressure in FY20.
TDG TransDigm
$568.32

9.81 (1.76%)

08/07/19
RHCO
08/07/19
NO CHANGE
Target $560
RHCO
Buy
TransDigm price target raised to $560 from $510 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on TransDigm to $560 after its Q3 earnings beat and record organic revenue growth of 11.8%. With the management indicating that its Esterline integration is tracking ahead of expectations, the analyst is also keeping his Buy rating on the stock, adding that the company is still the "best value creator in the industrial complex."
09/24/19
LEHM
09/24/19
NO CHANGE
LEHM
Barclays sees aerospace aftermarket stocks continuing to outperform in 2020
Barclays analyst David Strauss' analysis of global airline flight schedules indicates ~3% flight hour growth through the end of 2019, or 200 to 250 basis points below typical levels, due to the combination of the Boeing (BA) MAX grounding and weaker underlying traffic demand. The analyst forecasts decelerating second half of 2019 aftermarket growth as a result, given airlines dependency on older out-of-warranty aircraft. However, even with expected return of MAX in 2020, he forecasts that the aftermarket still grows 6%-8% as incremental MAX flight hours "do little to dilute contribution of continued strong growth in the older out-of-warranty fleet, which is responsible for the majority of aftermarket demand." Among his coverage, Strauss says TransDigm (TDG) is the primary beneficiary of continued aftermarket strength while Woodward (WWD) also has significant exposure. He believes the aerospace aftermarket stocks will continue to outperform in 2020 "despite elevated relative valuations."
08/15/19
JEFF
08/15/19
NO CHANGE
Target $550
JEFF
Buy
TransDigm price target raised to $550 from $480 at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for TransDigm to $550 from $480 saying the company's revenues grew 12% organically in its fiscal Q3. With the recent acquisition of ESL performing better than expected, TransDigm's sales could advance 25% in fiscal 2020, driving a 20% advance in EBITDA, Kahyaoglu tells investors in a research note. Nonetheless, she keeps a Hold rating on the shares, believing the market has likely priced in the better than expected returns of ESL.
08/07/19
FBCO
08/07/19
NO CHANGE
Target $617
FBCO
Outperform
TransDigm price target raised to $617 from $539 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for $617 from $539 with ESL integration progressing better than expected: The analyst reiterates an Outperform rating on the shares.
ARMK Aramark
$43.90

0.25 (0.57%)

09/19/19
LEHM
09/19/19
NO CHANGE
Target $45
LEHM
Equal Weight
Aramark price target raised to $45 from $35 at Barclays
Barclays analyst Manav Patnaik raised his price target for Aramark to $45 from $35 while keeping an Equal Weight rating on the shares. With Mantle Ridge's 20% economic stake, followed a week later by CEO Eric Foss' retirement, "change is clearly coming" to Aramark, Patnaik tells investors in a research note. This has been well received by investors, adds the analyst, who notes the stock is up 24% since the report of Mantle's interest on May 30. However, Patnaik wants to see a new management team articulate upcoming changes before becoming more constructive on the shares. His analysis suggests n "limited M&A optionality" for Aramark. While cost savings can drive earnings upside, a further valuation re-rating from here will have to come from organic growth acceleration, says Patnaik.
10/01/19
BOFA
10/01/19
NO CHANGE
BOFA
Top 10 US Ideas for Q4 at BofA/Merrill
BofA/Merrill introduced the Top 10 US Ideas for Q4 2019. The list's seven Buys are Aramark (ARMK), Salesforce (CRM), Disney (DIS), Dover (DOV), New York Community Bancorp (NYCB), Raytheon (RTN), and Target (TGT). Underperform's are Floor & Decor (FND), Gap (GPS), and Terex (TEX).
11/15/19
STFL
11/15/19
NO CHANGE
Target $49
STFL
Buy
Aramark quarter 'could be sloppy' given recent activist shakeup, says Stifel
Stifel analyst Shlomo Rosenbaum said he would not be surprised if Aramark's Q4 "numbers are sloppy" given the activist investor stake announcement that resulted in a change of board composition, exit of the prior CEO and hiring of a new CEO during the quarter. Though it might be early for a new CEO to put forth his new operating plan, Rosenbaum thinks the focus should be on the room for improvement, he stated. When John Zillmer does put forth his plan, Rosenbaum expects it to be "solid" with a focus on allocating capital to the appropriate areas, the analyst added, leading him to maintain a Buy rating and $49 price target on Aramark shares.
11/15/19
GDHS
11/15/19
NO CHANGE
GDHS
Gordon Haskett says Ackman, Icahn could be buyer behind Nomura's Netflix stake
Don Bilson, who heads Gordon Haskett's event-driven research team, said in a note prior to the open that Nomura's largest stock purchase last quarter was Netflix (NFLX), noting that the Japanese bank "put Mantle Ridge into Aramark (ARMK) and Carl Icahn into HP (HPQ) via a swap or some sort of options trade that remained on Nomura's books" previously. He speculated Bill Ackman could be the buyer behind Nomura's stakeholding, even "though there is nothing for an activist to do" at Netflix, given it fits the pattern of some other Pershing Square stock investments and Ackman mentioned not long ago that he had built a new, unnamed position. If it's not Ackman, "we suppose it could be Carl Icahn who just proved he knows who to call at Nomura" and his son, who previously got Icahn into the stock, is set to rejoin his fund shortly, Argenti wrote in his pre-open note.
KSS Kohl's
$58.39

-0.71 (-1.20%)

11/14/19
WEDB
11/14/19
NO CHANGE
Target $53
WEDB
Neutral
Kohl's price target raised to $53 from $48 at Wedbush
Wedbush analyst Jen Redding raised her price target for Kohl's to $53 from $48 ahead of the company's Q3 earnings reports scheduled for November 19. Although she sees upside to consensus numbers for Q3, Redding tells investors in a research note that she has lower visibility into guidance and commentary surrounding Q4 revenue and promotional trends. Redding says she "leans cautious" into the print, especially given lofty investor expectations. She maintains a Neutral rating on the shares.
08/21/19
GUGG
08/21/19
NO CHANGE
Target $60
GUGG
Buy
Kohl's [price target lowered to $60 from $70 at Guggenheim
Guggenheim analyst Robert Drbul lowered his price target for Kohl's to $60 from $70 to reflect lower sales/more pronounced gross margin contraction following quarterly results. The analyst reiterates a Buy rating on the shares as he believes management has the playbook to drive positive comps in the second half of 2019.
10/23/19
10/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Walgreens Boots Alliance (WBA) downgraded to Neutral from Overweight at JPMorgan with analyst Lisa Gill saying she based on her relative rating methodology, seeing better opportunities for upside in other companies within her coverage universe at the current time. 2. Cheniere Energy Partners (CQP) downgraded to Underperform at Raymond James with analyst Justin Jenkins saying that while his firm's North American energy macro outlook remains favorable for exporters from a supply-push perspective, he sees this as priced into Cheniere shares. 3. Resideo (REZI) downgraded to Perform from Outperform at Oppenheimer with analyst Ian Zaffino saying the company, once again, revised guidance negatively. 4. ServiceNow (NOW) downgraded to Neutral from Buy at Mizuho with analyst Gregg Moskowitz saying the company last night surprisingly announced the impending departure of CEO John Donahoe, who is going to head Nike (NKE), and lowered its full year guidance due to currency. 5. Kohl's (KSS) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/23/19
EVER
10/23/19
DOWNGRADE
EVER
In Line
Kohl's downgraded to In Line from Outperform at Evercore ISI

TODAY'S FREE FLY STORIES

ACB

Aurora Cannabis

$2.52

-0.095 (-3.63%)

21:25
12/10/19
12/10
21:25
12/10/19
21:25
Conference/Events
Aurora Cannabis management to meet with Cantor Fitzgerald. »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

, SPX

S&P 500

$0.00

(0.00%)

21:00
12/10/19
12/10
21:00
12/10/19
21:00
General news
White House Navarro says 'no indication' Dec 15th tariffs will be delayed »

Comments made on Fox…

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.07

0.025 (0.07%)

20:35
12/10/19
12/10
20:35
12/10/19
20:35
Hot Stocks
AT&T sets 2020 cost cut target of 4%, enters into accelerated $4B buyback »

John Stankey, COO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 29

    Jan

AEO

American Eagle

$15.13

-0.21 (-1.37%)

, PLCE

Children's Place

$70.67

0.68 (0.97%)

20:25
12/10/19
12/10
20:25
12/10/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AEO

American Eagle

$15.13

-0.21 (-1.37%)

PLCE

Children's Place

$70.67

0.68 (0.97%)

UNFI

United Natural Foods

$9.88

0.19 (1.96%)

VRA

Vera Bradley

$12.05

-0.09 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 18

    Dec

SAGE

Sage Therapeutics

$63.23

0.55 (0.88%)

20:15
12/10/19
12/10
20:15
12/10/19
20:15
Hot Stocks
Sage Therapeutics CSO buys 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$63.23

0.55 (0.88%)

20:14
12/10/19
12/10
20:14
12/10/19
20:14
Hot Stocks
Sage Therapeutics CEO buys 7.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XP

XP

$0.00

(0.00%)

20:11
12/10/19
12/10
20:11
12/10/19
20:11
Syndicate
XP 72.5M share IPO priced at $27.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PMT

PennyMac Mortgage

$22.75

-0.055 (-0.24%)

20:08
12/10/19
12/10
20:08
12/10/19
20:08
Syndicate
PennyMac Mortgage 8M share Spot Secondary priced at $22.10 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SALM

Salem Media

$1.49

0.03 (2.05%)

19:48
12/10/19
12/10
19:48
12/10/19
19:48
Hot Stocks
Salem Media cuts quarterly dividend to 2.5c from 6.5c per share »

The cash distribution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HROW

Harrow Health

$6.74

0.21 (3.22%)

19:46
12/10/19
12/10
19:46
12/10/19
19:46
Hot Stocks
Surgical Eyedrop wins return of patent from Harrow Health »

Novel Drug Solutions and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZUMZ

Zumiez

$34.02

-0.67 (-1.93%)

19:32
12/10/19
12/10
19:32
12/10/19
19:32
Hot Stocks
Zumiez director sells 5.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRC

Tejon Ranch

$16.07

0.02 (0.12%)

18:47
12/10/19
12/10
18:47
12/10/19
18:47
Hot Stocks
Ken County board of supervisors reaffirms approval of Grapevine at Tejon Ranch »

By a 5-0 vote, the Kern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXTR

Extreme Networks

$6.89

0.02 (0.29%)

, AVGO

Broadcom

$315.10

0.61 (0.19%)

18:43
12/10/19
12/10
18:43
12/10/19
18:43
Hot Stocks
Extreme Networks CEO: We've always been software driven »

In an interview on…

EXTR

Extreme Networks

$6.89

0.02 (0.29%)

AVGO

Broadcom

$315.10

0.61 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 12

    Dec

WDFC

WD-40

$194.80

-0.94 (-0.48%)

18:36
12/10/19
12/10
18:36
12/10/19
18:36
Hot Stocks
WD-40 names Garry Ridge as new board Chairman »

WD-40 announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ASPU

Aspen Group

$7.00

0.02 (0.29%)

, OLLI

Ollie's Bargain Outlet

$60.28

(0.00%)

18:34
12/10/19
12/10
18:34
12/10/19
18:34
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Aspen…

ASPU

Aspen Group

$7.00

0.02 (0.29%)

OLLI

Ollie's Bargain Outlet

$60.28

(0.00%)

PLAY

Dave & Buster's

$40.07

-0.2 (-0.50%)

PLT

Plantronics

$22.93

-0.44 (-1.88%)

CHH

Choice Hotels

$97.40

-0.03 (-0.03%)

LDOS

Leidos

$89.63

-0.47 (-0.52%)

GME

GameStop

$6.50

0.18 (2.85%)

CORV

Correvio

$1.39

(0.00%)

AQST

Aquestive Therapeutics

$7.60

-0.14 (-1.81%)

KIDS

OrthoPediatrics

$38.40

-0.35 (-0.90%)

MDGL

Madrigal Pharmaceuticals

$118.45

1.16 (0.99%)

RCKT

Rocket Pharmaceuticals

$24.22

1.22 (5.30%)

MNTA

Momenta

$18.09

0.19 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 13

    Dec

  • 16

    Dec

  • 24

    Dec

  • 30

    Dec

NFLX

Netflix

$293.21

-9.27 (-3.06%)

, UBER

Uber

$27.89

0.18 (0.65%)

18:27
12/10/19
12/10
18:27
12/10/19
18:27
Periodicals
Peru seeks sales taxes from Netflix, Uber, Spotify, Reuters says »

Claudia Suarez of the…

NFLX

Netflix

$293.21

-9.27 (-3.06%)

UBER

Uber

$27.89

0.18 (0.65%)

SPOT

Spotify

$145.73

-0.71 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

UBS

UBS

$11.95

-0.07 (-0.58%)

18:25
12/10/19
12/10
18:25
12/10/19
18:25
Periodicals
Judge rebuffs UBS' effort to reject U.S. lawsuit, Reuters reports »

U.S. District Judge Margo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

18:25
12/10/19
12/10
18:25
12/10/19
18:25
General news
Treasury Market Summary »

Treasury Market Summary:…

AKS

AK Steel

$3.41

0.08 (2.40%)

, MT

ArcelorMittal

$17.66

-0.05 (-0.28%)

18:22
12/10/19
12/10
18:22
12/10/19
18:22
Hot Stocks
USW union expresses support for new USMCA »

United Steelworkers…

AKS

AK Steel

$3.41

0.08 (2.40%)

MT

ArcelorMittal

$17.66

-0.05 (-0.28%)

NUE

Nucor

$57.76

0.005 (0.01%)

STLD

Steel Dynamics

$34.89

-0.21 (-0.60%)

X

U.S. Steel

$13.88

-0.215 (-1.53%)

TMST

TimkenSteel

$7.23

0.12 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHH

Choice Hotels

$97.40

-0.03 (-0.03%)

, PLT

Plantronics

$22.93

-0.44 (-1.88%)

18:16
12/10/19
12/10
18:16
12/10/19
18:16
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

Choice Hotels…

CHH

Choice Hotels

$97.40

-0.03 (-0.03%)

PLT

Plantronics

$22.93

-0.44 (-1.88%)

VSI

Vitamin Shoppe

$6.50

0.005 (0.08%)

FRG

Franchise Group

$14.39

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

XP

XP

$0.00

(0.00%)

18:10
12/10/19
12/10
18:10
12/10/19
18:10
Syndicate
Breaking Syndicate news story on XP »

XP prices IPO at $27,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MSFT

Microsoft

$151.18

-0.17 (-0.11%)

17:50
12/10/19
12/10
17:50
12/10/19
17:50
Hot Stocks
Microsoft, NTT in strategic alliance for enterprise digital transformation »

NTT Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GLD

SPDR Gold Shares

$137.96

0.37 (0.27%)

17:45
12/10/19
12/10
17:45
12/10/19
17:45
Hot Stocks
SPDR Gold Shares holdings fall to 885.93MT from 886.23MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBZ

CBIZ

$27.10

0.16 (0.59%)

17:40
12/10/19
12/10
17:40
12/10/19
17:40
Hot Stocks
CBIZ chairman Gerard sells 64,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XERS

Xeris Pharmaceuticals

$8.99

0.14 (1.58%)

17:38
12/10/19
12/10
17:38
12/10/19
17:38
Hot Stocks
Xeris Pharmaceuticals reports 'positive' phase 2 data in glucagon study »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.